Cerus Corporation Common Stock (CERS)
Stock · NASDAQ · Health Care
$2.17as of 10/16/2026
Price chart
CERS Signal Track Record
How signals performed across all stocks →What CERS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | -1.2% | 50% | September 17, 2026 |
| Bollinger Band Breakout | 23 | -1.6% | 43% | June 29, 2026 |
| Bollinger Band Breakdown | 20 | +8.4% | 65% | September 30, 2026 |
| 200-Day Moving Average TouchActive now | 20 | -4.1% | 40% | September 28, 2026 |
| Any 20-session window (baseline) | -2.2% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CERS
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Sys…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 261
- Website
- www.cerus.com/
Fundamentals
- 1-day range
- $2.17$2.29
- Market cap
- $467.54M
- P/E (trailing)
- —
- P/E (forward)
- -436.00
- EPS (trailing)
- $-0.03
- Dividend yield
- —
- Beta
- 1.85
- Avg. volume
- 2.17M
How Cerus Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Cerus Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- CERSCerus Corporation Common Stock$2.18▼ 3.54%Market cap $467.54MP/E —$1.38$3.47
- SIShoulder Innovations Inc. Common Stock$18.09▼ 1.52%Market cap $465.16MP/E —$10.92$24.6
- NPCENeuropace Inc. Common Stock$12.24▼ 4.23%Market cap $473.90MP/E —$9.22$19.6
- OFIXOrthofix Medical Inc. Common Stock (DE)$9.38▼ 2.19%Market cap $428.47MP/E —$8.5$16.99
- MOBIMobia Medical Inc. Common Stock$8.09▼ 2.65%Market cap $409.63MP/E —$8.16$15.29
- CLPTClearPoint Neuro Inc. Common Stock$9.07▼ 5.91%Market cap $408.45MP/E —$8.27$28.1
- DCTHDelcath Systems Inc. Common Stock$14.08▼ 4.93%Market cap $534.05MP/E 962.21$8.12$17.42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CERS Cerus Corporation Common Stock | $467.54M | — | $2.18 | ▼ 3.54% | $1.38$3.47 |
| SI Shoulder Innovations Inc. Common Stock | $465.16M | — | $18.09 | ▼ 1.52% | $10.92$24.6 |
| NPCE Neuropace Inc. Common Stock | $473.90M | — | $12.24 | ▼ 4.23% | $9.22$19.6 |
| OFIX Orthofix Medical Inc. Common Stock (DE) | $428.47M | — | $9.38 | ▼ 2.19% | $8.5$16.99 |
| MOBI Mobia Medical Inc. Common Stock | $409.63M | — | $8.09 | ▼ 2.65% | $8.16$15.29 |
| CLPT ClearPoint Neuro Inc. Common Stock | $408.45M | — | $9.07 | ▼ 5.91% | $8.27$28.1 |
| DCTH Delcath Systems Inc. Common Stock | $534.05M | 962.21 | $14.08 | ▼ 4.93% | $8.12$17.42 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Jensen Chrystal · August 17, 2026 · Sale30.0K @ $2.98
- Vivek K. Jayaraman · July 16, 2026 · Sale16.7K @ $3.16
- Vivek K. Jayaraman · July 1, 2026 · Grant369.7K
- Vivek K. Jayaraman · July 1, 2026 · Grant554.5K
- Vivek K. Jayaraman · June 30, 2026 · Sale42.4K @ $2.94
- Vivek K. Jayaraman · June 30, 2026 · Grant80.0K
- Jensen Chrystal · June 30, 2026 · Sale24.3K @ $2.94
- Jensen Chrystal · June 30, 2026 · Grant55.0K
- Kevin Dennis Green · June 30, 2026 · Sale33.7K @ $2.94
- Kevin Dennis Green · June 30, 2026 · Grant63.6K
- William Mariner Greenman · June 30, 2026 · Sale101.9K @ $2.94
- William Mariner Greenman · June 30, 2026 · Grant192.5K
- Eric Bjerkholt · June 9, 2026 · Sale20.5K @ $2.6
- Ann Lucena · June 2, 2026 · Grant60.0K
- Eric Bjerkholt · June 2, 2026 · Grant60.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 148.38M
- Total value held
- $262.49M
- Institutional holders
- 164
- Unknown21.58M
- Unknown19.16M
- Unknown10.75M
- Unknown10.01M
- Unknown8.13M
- Unknown5.28M
- Unknown4.64M
- Unknown4.52M
- Unknown4.52M
- Unknown4.24M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Cerus to Present at 2026 AABB Annual Meeting
Cerus Corporation announced it will host a workshop and present abstracts at the upcoming 2026 AABB Annual Meeting. This event highlights the company's ongoing scientific engagement and clinical data sharing within the blood banking community. The announcement serves as a routine corporate update, providing context for the stock's current trading position near its support levels.
Cerus to Present at 2026 AABB Annual Meeting. Cerus Corporation announced it will host a workshop and present abstracts at the upcoming 2026 AABB Annual Meeting. This event highlights the company's ongoing scientific engagement and clinical data sharing within the blood banking community. The announcement serves as a routine corporate update, providing context for the stock's current trading position near its support levels.